Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

South Korea Isolating Hundreds Amid MERS Outbreak

June 1, 2015 3:52 pm | by Seth Augenstein, Digital Reporter | News | Comments

South Korea reported two additional cases of Middle East Respiratory Syndrome coronavirus, or MERS, on Sunday. Read more...


ASCO 2015 Highlights

June 1, 2015 2:05 pm | by Stephanie Guzowski, Editor | News | Comments

Here are some of the top news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting. Read more...


Researcher Discovers Metabolite of Prostate Cancer Drug More Effective at Treating Aggressive Tumors

June 1, 2015 1:35 pm | by Cleveland Clinic | News | Comments

Cleveland: Cleveland Clinic researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, abiraterone (Abi), has more anti-cancer properties than its precursor. The research will be published online in Nature. Read more...


Available Genetic Data Could Help Doctors Prescribe More Effective Cardiovascular Drugs

June 1, 2015 1:30 pm | by University of Chicago | News | Comments

There is a wealth of published information describing interactions between drugs used to treat cardiovascular disease and the genetic variations that can affect how patients respond to them. But few heart specialists make routine use of this potentially life-saving data. Read more...

Amgen: Phase 3 Study Evaluating Once-Weekly Carfilzomib in Myeloma

June 1, 2015 1:23 pm | News | Comments

Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule. Read more...


AMRI, HarkerBIO Ink Collaborative Agreement

June 1, 2015 1:16 pm | News | Comments

Albany Molecular Research Inc. announced today that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. Read more...


More Cancer Success with Drugs That Enlist Immune System

June 1, 2015 1:12 pm | by By Lindsey Tanner, AP Medical Writer | News | Comments

For the first time, a major study shows that a drug targeting the body's disease-fighting immune system may improve survival for the most common form of lung cancer. Read more...


ASCO 2015: AstraZeneca, MedImmune Present Positive Immuno-oncology Combination Data

June 1, 2015 8:53 am | News | Comments

MEDI4736 and tremelimumab target two different tumor escape pathways; engaging the immune system to fight the cancer’s immune-evading tactics and maintaining tumor specific T-cell responses. Read more...


Study Could Explain Why Ovarian Cancer Treatments Fail

June 1, 2015 8:42 am | by University of Queensland | News | Comments

Ovarian cancer cells can lock into survival mode and avoid being destroyed by chemotherapy, an international study reports. Read more...


EULAR 2015: Roche to Announce New Data in RA, Severe Inflammatory Disorders

June 1, 2015 8:32 am | News | Comments

Roche announced that new data in rheumatoid arthritis and other severe autoimmune conditions will be presented at the European League Against Rheumatism Annual Congress in Rome. Read more...


Study in Nigeria Finds 1 in 10 Malaria Drugs Are Poor Quality

June 1, 2015 8:31 am | by London School of Hygiene & Tropical Medicine | News | Comments

Substandard medicines more prevalent than fakes in world’s most malaria-burdened country. Read more...


Hong Kong Quarantines 18 Over MERS Fears

June 1, 2015 8:30 am | by The Associated Press | News | Comments

Hong Kong authorities quarantined 18 fellow passengers of a South Korean man who arrived in the city infected with MERS. Read more...


Pfizer's Palbociclib Shows Promise Against Breast Cancer

June 1, 2015 8:28 am | News | Comments

Results from the Phase 3 PALOMA-3 study were featured in a press briefing during the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO). Read more...


MDMA, aka Ecstasy, May Be New Treatment for Autism’s Social Anxiety

May 29, 2015 12:34 pm | by Seth Augenstein, Digital Reporter | News | Comments

A recreational drug known for making people uninhibited and getting them dancing in clubs could get a new use: to help treat social anxiety among autistic adults, according to a new proposal by a group of researchers. Read more...


Drug Discovery Spotlight: Immuno-Oncolytic Therapy Advances; Suicidal Behavior Ends Co-Development of Psoriasis Drug

May 29, 2015 12:24 pm | by Stephanie Guzowski, Editor | News | Comments

From cancer therapies composed of herpes and vaccinia viruses to pharma collaborations that crumbled, here are your headlines this week. Read more…



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.